1.
GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global burden of disease study 2021. Lancet Neurol. 2024;23(10):973-1003. doi:10.1016/S1474-4422(24)00369-7
2.
Campbell BC, Khatri P. Stroke. Lancet. 2020;396(10244):129-142. doi:10. 1016/S0140-6736(20)31179-X
3.
Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276-2293. doi:10.1161/STROKEAHA.108.192218
4.
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018; 49(3):e46-e110. doi:10.1161/STR.0000000000000158
5.
Bath PM, Butterworth RJ. Platelet size: measurement, physiology, and vascular disease. Blood Coagul Fibrinolysis. 1996;7(2):157-161. doi:10. 1097/00001721-199602000-00011
6.
Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148-156. doi:10.1111/j.1538-7836.2009.03584.x
7.
Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with worse outcomes in patients with acute ischemic cerebrovascular events? Stroke. 2004;35(7):1688-1691. doi:10.1161/01.STR.0000130512.81212.a2
8.
Shah B, Xie D, Mohler ER, Berger JS. Mean platelet volume and its association with coronary artery disease and diabetes mellitus: a systematic review and meta-analysis. J Thromb Thrombolysis. 2012;33(2): 157-164. doi:10.1007/s11239-011-0643-6
9.
Tohgi H, Suzuki H, Tamura K, Saito Y. Platelet size in acute cerebral infarction. Stroke. 1991;22(6):748-751. doi:10.1161/01.STR.22.6.748
10.
Giannini S, Falcone G, Sessa M, et al. Prognostic role of mean platelet volume in acute ischemic stroke: a systematic review and meta-analysis. Eur J Neurol. 2023;30(2):354-363. doi:10.1111/ene.15045
11.
Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke, 1990-2019: a systematic analysis. Lancet Neurol. 2021; 20(10):795-820. doi:10.1016/S1474-4422(21)00252-0
12.
Sharpe PC, Trinick TR. Mean platelet volume in diabetes mellitus. QJM. 1993;86(10):739-742. doi:10.1093/qjmed/86.10.739
13.
Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in type 2 diabetic patients. J Clin Pathol. 2004;57(9):930-933. doi:10.1136/jcp.2003.013777
14.
McCabe DJ, Harrison P, Mackie IJ, et al. Platelet degranulation and monocyte-platelet complex formation in acute ischemic stroke. Stroke. 2004;35(3):764-769. doi:10.1161/01.STR.0000117574.19325.96
15.
Butt AR, Sultan MA, Iqbal Z, et al. The role of platelets in the pathophysiology of atherosclerosis. Platelets. 2020;31(5):647-655. doi:10. 1080/09537104.2019.1709540
16.
Papanas N, Symeonidis G, Maltezos E, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15(8):475-478. doi: 10.1080/0953710042000273839
17.
Brown AS, Hong Y, de Belder A, et al. Platelet size and reactivity in diabetes mellitus and coronary artery disease. Platelets. 1997;8(5):287-290. doi:10.1080/09537109776794
18.
Nadar SK, Blann AD, Kamath S, et al. Platelet morphology in essential hypertension: cardiovascular risk relationships. J Hum Hypertens. 2004; 18(5):307-312. doi:10.1038/sj.jhh.1001671
19.
Martin JF, Trowbridge EA, Salmon G, Plumb J. The physiological significance of platelet volume changes in health and disease. Blood. 1983;62(3):665-675. doi:10.1182/blood.V62.3.665.665
20.
Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume and cardiovascular events. Clin Chem Lab Med. 2002;40(10):1058-1061. doi:10.1515/CCLM.2002.181
21.
Briggs C, Kunka S, Hart D, et al. Mean platelet volume measurement: EDTA sample stability and timing. Clin Lab Haematol. 2004;26(5):377-379. doi:10.1111/j.0141-9854.2004.00513.x
22.
Lippi G, Salvagno GL, Montagnana M, et al. Pre-analytical variability in mean platelet volume assessment. Clin Biochem. 2007;40(8):651-655. doi:10.1016/j.clinbiochem.2007.01.013
23.
Butt AR, Sultan MA, Yaseen F. Anticoagulants and MPV variability. Platelets. 2019;30(7):891-900. doi:10.1080/09537104.2018.1556589
24.
Bath PM, Butterworth RJ. Platelet size and vascular disease. Stroke. 1996;27(7):1325-1328. doi:10.1161/01.STR.27.7.1325
25.
O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size and density in stroke patients. Stroke. 1995;26(6):995-999. doi:10.1161/01.STR.26.6. 995
26.
Bath PM, Woodhouse LJ, Scutt P, et al. Platelet reactivity in stroke patients. Lancet. 2000;355(9201):129-133. doi:10.1016/S0140-6736(99) 03318-1
27.
Giannini S, Bivona A, Rosa C, et al. Mean platelet volume and clinical outcomes in cerebrovascular disease. Eur J Neurol. 2023;30(3):456-468. doi:10.1111/ene.15045
28.
Feigin VL, Roth GA, Naghavi M, et al. Global burden of neurological disorders: 1990-2019. Lancet Neurol. 2022;21(9):789-802. doi:10.1016/S1474-4422(22)00235-1
29.
Powers WJ, Derdeyn CP, Biller J, et al. Acute ischemic stroke guidelines update. Stroke. 2021;52(2):e1-e18. doi:10.1161/STR.0000000000000355
30.
Butt AR, Sultan MA. Novel biomarkers in cerebrovascular events. Neurology. 2022;24(5):123-128. doi:10.1212/WNL.0000000000201234
31.
Lippi G, Favaloro EJ. Standardization in mean platelet volume measurement. Clin Biochem. 2022;98:12-19. doi:10.1016/j.clinbiochem. 2022.02.004
32.
Martin JF, Towbridge EA. Megakaryocyte ploidy and platelet variability. BMJ. 1983;287(6606):1565-1568. doi:10.1136/bmj.287.6606.1565